J&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports
Apollo Global Management is in talks to acquire Johnson & Johnson's orthopedics unit, DePuy Synthes, for up to $20 billion. J&J may also spin off the unit, which generated $9.3 billion in 2025. The deal follows private equity interest in healthcare companies, with J&J previously announcing plans to separate DePuy Synthes.
How this was made
The 30-second read
Why it matters
The transaction could reshape the competitive landscape in orthopedic devices and impact both companies' balance sheets.
Market read
A potential $20 billion M&A deal in the healthcare sector is highly material for both JNJ and APO stocks.
What to watch
Ongoing litigation over J&J's hip implants may affect the attractiveness and pricing of DePuy Synthes.
Background
Apollo Global Management is actively seeking large healthcare assets; J&J is exploring strategic options for its orthopedics business amid litigation.
Ticker impact
Apollo Global Management is in talks to acquire Johnson & Johnson's orthopedics unit DePuy Synthes in a potential $20 billion deal.
JNJ may see a modest premium as investors price in a possible spin‑off; APO could rally on deal‑related upside.
Deal size is material and represents the first public disclosure of the transaction.
Apollo Global Management is the prospective buyer of J&J's DePuy Synthes orthopedics unit in a $20 billion transaction.
APO may experience a price increase as the market prices in the large healthcare exposure.
First report of a major M&A opportunity for Apollo.
Market effects
Healthcare equipment sector could see consolidation pressure and valuation re‑rating.
U.S. healthcare and private‑equity markets may react to the large deal size.
One of the biggest healthcare M&A deals of the year, influencing global M&A sentiment.
Counterpoint
Deal could face regulatory hurdles or valuation disputes, potentially delaying or derailing the transaction.
Key entities
- companyJohnson & Johnson
Parent of DePuy Synthes, exploring sale or spin‑off.
- companyApollo Global Management
Private‑equity firm targeting a $20 billion acquisition.
